SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 28th, 2020 • Emerald Bioscience, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July ____, 2020, between Emerald Bioscience, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT EMERALD BIOSCIENCE, INC.Common Stock Purchase Warrant • July 28th, 2020 • Emerald Bioscience, Inc. • Pharmaceutical preparations
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Emerald Bioscience, Inc., a Nevada corporation (the ”Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of July 20, 2020.
STRICTLY CONFIDENTIAL Emerald Bioscience, Inc.Letter Agreement • July 28th, 2020 • Emerald Bioscience, Inc. • Pharmaceutical preparations • New York
